Study of Pharmacokinetic, Safety, Immunogenicity and Efficacy of CMAB819 and Nivolumab in R/M HNSCC

Clinical trial NCT04659369 · TERMINATED

Trial details

NCT number: NCT04659369
Sponsor: Taizhou Mabtech Pharmaceutical Co.,Ltd
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of the Head and Neck

Start date: 2020-09-24
Primary completion: 2023-10-16
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.